Anti-GM2 ADCC Enhanced Antibody (BIW-8962) is an ADCC enhanced antibody produced by our Afuco™ platform. BIW-8962 is a humanized anti-ganglioside GM2 (GM2) monoclonal antibody, exhibited a potent ADCC and less potent CDC activity. Currently BIW-8962 is being investigated in a Phase 1 study in patients with multiple myeloma.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-406 | Recombinant Anti-GM2 Antibody | ELISA, WB, IF, FuncS | IgG |
MHH-406 | Recombinant Human Anti-GM2 Antibody | WB, Neut, FuncS | IgG |
HPAB-S0039-YC | Human Anti-GM2 Recombinant Antibody (clone KM8966) | ELISA, ADCC | Human IgG |
HPAB-S0040-YC | Human Anti-GM2 Recombinant Antibody (clone KM8967) | ELISA, ADCC | Human IgG |
FAMAB-1396CQ | Mouse Anti-GM2 Recombinant Antibody (clone E1) | ELISA, IHC | Mouse IgG1 |
There are currently no Customer reviews or questions for AFC-307CL. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.